FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1995726392> ?p ?o ?g. }

• W1995726392 endingPage "794" @default.
• W1995726392 startingPage "784" @default.
• W1995726392 abstract "Combined treatment with cyclosporine microemulsion preconcentrate (CyA MEPC) and steroids has been widely used for idiopathic membranous nephropathy (IMN) associated with steroid-resistant nephrotic syndrome (SRNS). Recent studies have shown that once-a-day and preprandial administration of CyA MEPC is more advantageous than the conventional twice-a-day administration in achieving the target blood CyA concentration at 2 h post dose (C2). We designed a randomized trial to compare these administrations. IMN patients with SRNS (age 16–75 years) were divided prospectively and randomly into 2 groups. In group 1 (n = 23), 2–3 mg/kg body weight (BW) CyA MEPC was given orally once a day before breakfast. In group 2 (n = 25), 1.5 mg/kg BW CyA MEPC was given twice a day before meals. CyA + prednisolone was continued for 48 weeks. Group 1 showed a significantly higher cumulative complete remission (CR) rate (p = 0.0282), but not when incomplete remission 1 (ICR1; urine protein 0.3–1.0 g/day) was added (p = 0.314). Because a C2 of 600 ng/mL was determined as the best cut-off point, groups 1 and 2 were further divided into subgroups A (C2 ≥600 ng/mL) and B (C2 <600 ng/mL). Groups 1A and 2A revealed significantly higher cumulative remission (CR + ICR1) (p = 0.0069) and CR-alone (p = 0.0028) rates. On the other hand, 3 patients with high CyA levels (C2 >900 ng/mL) in Group 1A were withdrawn from the study because of complications. CyA + prednisolone treatment is effective for IMN with associated SRNS at a C2 of ≥600 ng/mL. To achieve remission, preprandial once-a-day administration of CyA at 2–3 mg/kg BW may be the most appropriate option. However, we should adjust the dosage of CyA by therapeutic drug monitoring to avoid complications." @default.
• W1995726392 created "2016-06-24" @default.
• W1995726392 creator A5001116847 @default.
• W1995726392 creator A5003439019 @default.
• W1995726392 creator A5009634100 @default.
• W1995726392 creator A5025431711 @default.
• W1995726392 creator A5027883206 @default.
• W1995726392 creator A5031209396 @default.
• W1995726392 creator A5036113498 @default.
• W1995726392 creator A5043121221 @default.
• W1995726392 creator A5045969631 @default.
• W1995726392 creator A5049605722 @default.
• W1995726392 creator A5050564961 @default.
• W1995726392 creator A5053312419 @default.
• W1995726392 creator A5053416358 @default.
• W1995726392 creator A5056772898 @default.
• W1995726392 creator A5076793591 @default.
• W1995726392 creator A5078494019 @default.
• W1995726392 creator A5078518474 @default.
• W1995726392 creator A5080548800 @default.
• W1995726392 creator A5087282460 @default.
• W1995726392 date "2013-12-23" @default.
• W1995726392 modified "2023-10-01" @default.
• W1995726392 title "Significance of combined cyclosporine−prednisolone therapy and cyclosporine blood concentration monitoring for idiopathic membranous nephropathy with steroid-resistant nephrotic syndrome: a randomized controlled multicenter trial" @default.
• W1995726392 cites W1569503463 @default.
• W1995726392 cites W1972012473 @default.
• W1995726392 cites W1984581375 @default.
• W1995726392 cites W1988272035 @default.
• W1995726392 cites W1991878257 @default.
• W1995726392 cites W2001921478 @default.
• W1995726392 cites W2002034691 @default.
• W1995726392 cites W2006666860 @default.
• W1995726392 cites W2009576981 @default.
• W1995726392 cites W2012632997 @default.
• W1995726392 cites W2024720297 @default.
• W1995726392 cites W2028682960 @default.
• W1995726392 cites W2033459844 @default.
• W1995726392 cites W2044080899 @default.
• W1995726392 cites W2049840779 @default.
• W1995726392 cites W2055379700 @default.
• W1995726392 cites W2059026853 @default.
• W1995726392 cites W2060189023 @default.
• W1995726392 cites W2062099920 @default.
• W1995726392 cites W2068127163 @default.
• W1995726392 cites W2080193466 @default.
• W1995726392 cites W2082043357 @default.
• W1995726392 cites W2087923508 @default.
• W1995726392 cites W2105264067 @default.
• W1995726392 cites W2115472834 @default.
• W1995726392 cites W2116986363 @default.
• W1995726392 cites W2130104807 @default.
• W1995726392 cites W2144479843 @default.
• W1995726392 cites W2166158692 @default.
• W1995726392 cites W2483966432 @default.
• W1995726392 cites W2594454279 @default.
• W1995726392 cites W2045781549 @default.
• W1995726392 doi "https://doi.org/10.1007/s10157-013-0925-2" @default.
• W1995726392 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4194018" @default.
• W1995726392 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24363128" @default.
• W1995726392 hasPublicationYear "2013" @default.
• W1995726392 type Work @default.
• W1995726392 sameAs 1995726392 @default.
• W1995726392 citedByCount "19" @default.
• W1995726392 countsByYear W19957263922014 @default.
• W1995726392 countsByYear W19957263922015 @default.
• W1995726392 countsByYear W19957263922016 @default.
• W1995726392 countsByYear W19957263922017 @default.
• W1995726392 countsByYear W19957263922018 @default.
• W1995726392 countsByYear W19957263922019 @default.
• W1995726392 countsByYear W19957263922021 @default.
• W1995726392 countsByYear W19957263922022 @default.
• W1995726392 countsByYear W19957263922023 @default.
• W1995726392 crossrefType "journal-article" @default.
• W1995726392 hasAuthorship W1995726392A5001116847 @default.
• W1995726392 hasAuthorship W1995726392A5003439019 @default.
• W1995726392 hasAuthorship W1995726392A5009634100 @default.
• W1995726392 hasAuthorship W1995726392A5025431711 @default.
• W1995726392 hasAuthorship W1995726392A5027883206 @default.
• W1995726392 hasAuthorship W1995726392A5031209396 @default.
• W1995726392 hasAuthorship W1995726392A5036113498 @default.
• W1995726392 hasAuthorship W1995726392A5043121221 @default.
• W1995726392 hasAuthorship W1995726392A5045969631 @default.
• W1995726392 hasAuthorship W1995726392A5049605722 @default.
• W1995726392 hasAuthorship W1995726392A5050564961 @default.
• W1995726392 hasAuthorship W1995726392A5053312419 @default.
• W1995726392 hasAuthorship W1995726392A5053416358 @default.
• W1995726392 hasAuthorship W1995726392A5056772898 @default.
• W1995726392 hasAuthorship W1995726392A5076793591 @default.
• W1995726392 hasAuthorship W1995726392A5078494019 @default.
• W1995726392 hasAuthorship W1995726392A5078518474 @default.
• W1995726392 hasAuthorship W1995726392A5080548800 @default.
• W1995726392 hasAuthorship W1995726392A5087282460 @default.
• W1995726392 hasBestOaLocation W19957263921 @default.
• W1995726392 hasConcept C126322002 @default.
• W1995726392 hasConcept C126894567 @default.
• W1995726392 hasConcept C141071460 @default.
• W1995726392 hasConcept C168563851 @default.
• W1995726392 hasConcept C2775946357 @default.

• next